From May20 to22, 2026, Chongqing LBBC Medical Device Co., Ltd. proudly participated in the 31st Kazakhstan International Medical Exhibition held in Almaty. As a leading Chinese innovator in the medical device sector, the company gained significant attention from global medical professionals and industry partners.
At this international event, LBBC presented its flagship product — Xunning®️ Absorbable Hemostatic Powder, a cutting-edge hemostatic solution designed for surgical and trauma applications. The product’s fast-acting, fully absorbable, and biocompatible nature drew widespread interest from attending distributors, hospitals, and healthcare professionals.
Fast, Safe, and Efficient Hemostasis
Xunning®️ Absorbable Hemostatic Powder is a high-performance hemostatic agent developed through advanced bioengineering techniques. It offers rapid bleeding control with complete absorption and no toxic residue, making it ideal for a wide range of clinical scenarios. Visitors from Uzbekistan and neighboring countries praised the product for its clinical reliability and market potential.
Strong Engagement at the Exhibition Booth
Throughout the three-day event, LBBC’s international business team engaged in productive discussions with medical professionals and distribution partners from Uzbekistan, Kazakhstan, Russia, and other regions. Many expressed strong interest in potential partnerships, with several companies scheduling follow-up meetings and trial product requests on-site.
A Solid Step Toward Expanding in Central Asia
The successful exhibition marked a significant milestone in LBBC‘s global expansion strategy, especially in the Central Asian medical market. With growing international awareness of its Xunning®️ Hemostatic Powder, the company is poised to strengthen its presence and form lasting partnerships across the region.
If you want to know more about our product “Xunning®️ Hemostatic Powder”, fell free to contact us!